AAAAAA

   
Results: 1-15 |
Results: 15
Thymidine kinase as a proliferative marker: Clinical relevance in 1,692 primary breast cancer patients
Authors: Broet, P Romain, S Daver, A Ricolleau, G Quillien, V Rallet, A Asselain, B Martin, PM Spyratos, F
Citation: P. Broet et al., Thymidine kinase as a proliferative marker: Clinical relevance in 1,692 primary breast cancer patients, J CL ONCOL, 19(11), 2001, pp. 2778-2787
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
Authors: Hoang-Xuan, K He, J Huguet, S Mokhtari, K Marie, Y Kujas, M Leuraud, P Capelle, L Delattre, JY Poirier, J Broet, P Sanson, M
Citation: K. Hoang-xuan et al., Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression, NEUROLOGY, 57(7), 2001, pp. 1278-1281
Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants
Authors: Lemoine, A Pham, P Azoulay, D Saliba, F Emile, JF Saffroy, R Broet, P Bismuth, H Samuel, D Debuire, B
Citation: A. Lemoine et al., Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants, BLOOD, 98(5), 2001, pp. 1332-1338
A semiparametric approach for the two-sample comparison of survival times with long-term survivors
Authors: Broet, P De Rycke, Y Tubert-Bitter, P Lellouch, J Asselain, B Moreau, T
Citation: P. Broet et al., A semiparametric approach for the two-sample comparison of survival times with long-term survivors, BIOMETRICS, 57(3), 2001, pp. 844-852
Cytotoxic synergism of methioninase in combination with 5-fluorouracil andfolinic acid
Authors: Machover, D Zittoun, J Broet, P Metzger, G Orrico, M Goldschmidt, E Schilf, A Tonetti, C Tan, YY Delmas-Marsalet, B Luccioni, C Falissard, B Hoffman, RM
Citation: D. Machover et al., Cytotoxic synergism of methioninase in combination with 5-fluorouracil andfolinic acid, BIOCH PHARM, 61(7), 2001, pp. 867-876
Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study
Authors: Sanson, M Napolitano, M Yaya, R Keime-Guibert, F Broet, P Hoang-Xuan, K Delattre, JY
Citation: M. Sanson et al., Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study, J NEURO-ONC, 50(3), 2000, pp. 245-249
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone
Authors: Keime-Guibert, F Graus, F Fleury, A Rene, R Honnorat, J Broet, P Delattre, JY
Citation: F. Keime-guibert et al., Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone, J NE NE PSY, 68(4), 2000, pp. 479-482
Prognostic factors of recurrence and/or death in colorectal cancer: multistate modeling
Authors: Cyvoct, C Quantin, C Broet, P Benhamiche, AM Brunet-Lecomte, P D'Athis, P Faivre, J
Citation: C. Cyvoct et al., Prognostic factors of recurrence and/or death in colorectal cancer: multistate modeling, REV EPIDEM, 47(6), 1999, pp. 619-625
Unobserved covariates in the two-sample comparison of survival times: A maximin efficiency robust test
Authors: Broet, P Moreau, T Lellouch, J Asselain, B
Citation: P. Broet et al., Unobserved covariates in the two-sample comparison of survival times: A maximin efficiency robust test, STAT MED, 18(14), 1999, pp. 1791-1800
Data collection of treated end-stage renal failure patient care. Feasibility study
Authors: Stengel, B Landais, P Cordonnier, D Jacquelinet, C Guillon, MD Boutin, MB Broet, P Chanard, J
Citation: B. Stengel et al., Data collection of treated end-stage renal failure patient care. Feasibility study, NEPHROLOGIE, 20(1), 1999, pp. 29-40
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial
Authors: Broet, P Scholl, SM de la Rochefordiere, A Fourquet, A Moreau, T De Rycke, Y Asselain, B Pouillart, P
Citation: P. Broet et al., Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial, BREAST CANC, 58(2), 1999, pp. 151-156
Analyzing prognostic factors in breast cancer using a multistate model
Authors: Broet, P de la Rochefordiere, A Scholl, SM Fourquet, A De Rycke, Y Pouillart, P Mosseri, V Asselain, B
Citation: P. Broet et al., Analyzing prognostic factors in breast cancer using a multistate model, BREAST CANC, 54(1), 1999, pp. 83-89
Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study
Authors: Napolitano, M Keime-Guibert, F Monjour, A Lafitte, C Ameri, A Cornu, P Broet, P Delattre, JY
Citation: M. Napolitano et al., Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study, J NEURO-ONC, 45(3), 1999, pp. 229-235
Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor
Authors: Keime-Guibert, F Graus, F Broet, P Rene, R Molinuevo, JL Ascaso, C Delattre, JY
Citation: F. Keime-guibert et al., Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor, NEUROLOGY, 53(8), 1999, pp. 1719-1723
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study
Authors: Broet, P Spyratos, F Romain, S Quillien, V Daver, A Ricolleau, G Rallet, A Toulas, C Asselain, B
Citation: P. Broet et al., Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study, BR J CANC, 80(3-4), 1999, pp. 536-545
Risultati: 1-15 |